Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

This is a registry study — a large database — for people diagnosed with myelodysplastic syndromes (MDS) or therapy-related acute myeloid leukemia (t-AML). These are blood cancers where blood cells do not develop properly, often as a result of previous cancer treatment. The registry will collect clinical information over time to better understand these conditions and improve care. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with MDS or therapy-related AML - You are willing and able to provide written consent **You may NOT be eligible if...** - You are under 18 years old - You are unwilling or unable to give informed consent Talk to your doctor to see if this trial is right for you.